Clinical Trial Update: Study of Arixtra (Fondaparinux Sodium) to Prevent Blood Clots in Women Undergoing Abdominopelvic Surgery for Likely Gynecologic Malignancy [Phase 3]

View source ↗

Summary

Phase 3 trial of fondaparinux (Arixtra) to prevent venous thromboembolism in women undergoing abdominopelvic surgery for likely gynecologic cancer was terminate…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gynecologic Cancer
• Venous Thrombosis

Drugs mentioned

• ARIXTRA (fondaparinux sodium)

Snippet

Sponsor: University of Alabama at Birmingham | Conditions: Venous Thrombosis | Phase 3 | Status: TERMINATED | Results posted: 2012-03-09